Published in Biochem Biophys Res Commun on November 07, 1977
Effect of interferon on concentrations of cyclic nucleotides in cultured cells. Proc Natl Acad Sci U S A (1979) 0.94
Enhancement of basophil chemotaxis in vitro by virus-induced interferon. J Clin Invest (1981) 0.86
Species specificity of interferon action: maintenance and establishment of the antiviral state in the presence of a heterospecific nucleus. J Virol (1979) 0.81
Effect of cholera toxin on the antiviral and anticellular activities of human leukocyte interferon. Infect Immun (1979) 0.80
Effect of prostaglandins and cyclic adenosine 3',5'-monophosphate modulators on herpes simplex virus growth and interferon response in human cells. Infect Immun (1980) 0.78
Biosynthetic human interferon treatment of herpetic keratitis. Trans Am Ophthalmol Soc (1983) 0.75
Restoration of several morphological characteristics of normal fibroblasts in sarcoma cells treated with adenosine-3':5'-cyclic monphosphate and its derivatives. Proc Natl Acad Sci U S A (1971) 5.31
Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. Science (1982) 3.67
Replication of semliki forest virus: three forms of viral RNA produced during infection. Proc Natl Acad Sci U S A (1966) 3.23
Cytoplasmic structures associated with an arbovirus infection: loci of viral ribonucleic acid synthesis. J Virol (1968) 3.04
Defect in conversion of procollagen to collagen in a form of Ehlers-Danlos syndrome. Science (1973) 2.74
Localization of D-lactate dehydrogenase in native and reconstituted Escherichia coli membrane vesicles. J Biol Chem (1975) 2.64
Overexpression and overactivation of Akt in thyroid carcinoma. Cancer Res (2001) 2.51
Cytoplasmic fractions associated with Semliki Forest virus ribonucleic acid replication. J Virol (1967) 2.29
Antiviral activity of interferons. Bacteriol Rev (1977) 2.25
Analysis of arbovirus ribonucleic acid forms by polyacrylamide gel electrophoresis. J Virol (1971) 2.10
Genomic DNA released by dying cells induces the maturation of APCs. J Immunol (2001) 2.03
Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells. Endocrinology (2000) 2.01
Mechanism of interferon action: inhibition of viral messenger ribonucleic acid translation in L-cell extracts. J Virol (1972) 2.00
Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy. J Infect Dis (1982) 1.98
Membrane-associated replication complex in arbovirus infection. J Virol (1972) 1.83
Role of interferon during viremia. II. Protective action of circulating interferon. J Immunol (1966) 1.76
The epidemiology of childhood psychiatric disorders: prevalence findings from recent studies. J Am Acad Child Adolesc Psychiatry (1990) 1.73
Procollagen peptidase: an enzyme excising the coordination peptides of procollagen. Proc Natl Acad Sci U S A (1971) 1.73
Recombinant human gamma interferon inhibits simian malaria. Infect Immun (1986) 1.71
Interferons with special emphasis on the immune system. Adv Immunol (1983) 1.69
Membrane binding of input arbovirus ribonucleic acid: effect of interferon or cycloheximide. J Virol (1970) 1.66
Inhibition of interferon action by puromycin. J Immunol (1965) 1.65
Delayed hypersensitivity in Graves' disease and exophthalmos: identification of thyroglobulin in normal human orbital muscle. Endocrinology (1977) 1.64
Protein synthesis directed by an arbovirus. J Virol (1968) 1.63
Recurrent digital ischemia due to thrombosis of the persistent median artery. Plast Reconstr Surg (1997) 1.61
Mechanisms of active transport in isolated bacterial membrane vesicles. XV. Purification and properties of the membrane-bound D-lactate dehydrogenase from Escherichia coli. J Biol Chem (1973) 1.60
Simian virus 40-specific ribosome-binding proteins induced by a nondefective adenovirus 2-simian virus 40 hybrid. J Virol (1977) 1.59
Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule. Proc Natl Acad Sci U S A (1996) 1.56
Evasion of host defenses by measles virus: wild-type measles virus infection interferes with induction of Alpha/Beta interferon production. J Virol (2000) 1.55
Lysyl oxidase and rrg messenger RNA. Science (1991) 1.55
Specific membranous structures associated with the replication of group A arboviruses. J Virol (1972) 1.54
Tetanus toxin interactions with thyroid plasma membranes. Implications for structure and function of tetanus toxin receptors and potential pathophysiological significance. J Biol Chem (1977) 1.53
A selective defect of interferon alpha production in human immunodeficiency virus-infected monocytes. J Exp Med (1990) 1.53
Expression of gene rrg is associated with reversion of NIH 3T3 transformed by LTR-c-H-ras. Science (1990) 1.53
Replicative intermediate of an arbovirus. J Virol (1968) 1.51
Inhibition of murine leukemia virus production in chronically infected AKR cells: a novel effect of interferon. Proc Natl Acad Sci U S A (1974) 1.50
Interferon-directed inhibition of chronic murine leukemia virus production in cell cultures: lack of effect on intracellular viral markers. J Virol (1975) 1.49
Effect of interferon treatment on interferon production. J Immunol (1966) 1.49
Internal stabilization of autogenous rib cartilage grafts in rhinoplasty: a barrier to cartilage warping. Plast Reconstr Surg (1997) 1.48
Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides. Proc Natl Acad Sci U S A (1999) 1.48
Multicomponent structure of the thyrotropin receptor: relationship to Graves' disease. Life Sci (1983) 1.48
Thyrotropin-ganglioside interactions and their relationship to the structure and function of thyrotropin receptors. Proc Natl Acad Sci U S A (1976) 1.48
Potentiation of human interferon production by superinduction. J Natl Cancer Inst (1971) 1.47
Interferon induces morphologic reversion with elimination of extrachromosomal viral genomes in bovine papillomavirus-transformed mouse cells. Proc Natl Acad Sci U S A (1982) 1.46
Use of thyrotropin receptor (TSHR) mutants to detect stimulating TSHR antibodies in hypothyroid patients with idiopathic myxedema, who have blocking TSHR antibodies. J Clin Endocrinol Metab (1993) 1.46
Interferon binding: the first step in establishment of antiviral activity. Science (1967) 1.45
Integrated steady state rate equations and the determination of individual rate constants. J Biol Chem (1975) 1.45
The kinetic properties of spinach leaf glyoxylic acid reductase. J Biol Chem (1970) 1.44
Regulation of HIV replication in infected monocytes by IFN-alpha. Mechanisms for viral restriction. J Immunol (1990) 1.44
The binding of thyrotropin to isolated bovine thyroid plasma membranes. J Biol Chem (1973) 1.43
Cloning and characterization of a cDNA that encodes a 70-kDa novel human thyroid autoantigen. J Biol Chem (1989) 1.41
The prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves' disease. Thyroid (2000) 1.40
Caring for severely emotionally disturbed children and youth. Principles for a system of care. Child Today (1988) 1.39
Geranylgeranylated rho small GTPase(s) are essential for the degradation of p27Kip1 and facilitate the progression from G1 to S phase in growth-stimulated rat FRTL-5 cells. J Biol Chem (1997) 1.38
A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy. J Clin Endocrinol Metab (2010) 1.37
Thyrotropin effects on thyroid cells in culture. Effects of trypsin on the thyrotropin receptor and on thyrotropin-mediated cyclic 3':5'-AMP changes. J Biol Chem (1975) 1.37
Some factors affecting the interferon-induced antiviral state. Proc Soc Exp Biol Med (1967) 1.33
Structural and nonstructural proteins of an arbovirus. J Virol (1968) 1.33
Interferon inhibits mouse leukaemia virus release: an electron microscope study. J Gen Virol (1977) 1.31
Relationships of thyrotropin to exophthalmic-producing substance. Purification of homogeneous glycoproteins containing both activities from [3H]-labeled pituitary extracts. J Biol Chem (1970) 1.29
The relationship of growth and adenylate cyclase activity in cultured thyroid cells: separate bioeffects of thyrotropin. Endocrinology (1983) 1.29
Biochemical correlates of phenotypic reversion in interferon-treated mouse cells transformed by a human oncogene. Biochem Biophys Res Commun (1984) 1.29
Actinomycin D: inhibition of phospholipid synthesis in chick embryo cells. Science (1968) 1.28
Interferon action on parental Semliki forest virus ribonucleic acid. J Virol (1967) 1.28
Effects of thyrotropin on the thyroid cell membrane: hyperpolarization induced by hormone-receptor interaction. Proc Natl Acad Sci U S A (1977) 1.24
Thyrotropin receptors in thyroid plasma membranes. Characteristics of thyrotropin binding and solubilization of thyrotropin receptor activity by tryptic digestion. J Biol Chem (1975) 1.24
Physical, morphological, and biochemical alterations in the membrane of AKR mouse cells after interferon treatment. Proc Natl Acad Sci U S A (1978) 1.23
Restriction of HIV replication in infected T cells and monocytes by interferon-alpha. AIDS Res Hum Retroviruses (1990) 1.21
Cholera toxin interactions with thyrotropin receptors on thyroid plasma membranes. Proc Natl Acad Sci U S A (1976) 1.20
Primary gene products of an arbovirus. Biochem Biophys Res Commun (1969) 1.20
Antibodies that promote thyroid growth. A distinct population of thyroid-stimulating autoantibodies. N Engl J Med (1983) 1.19
Regulation of ppp(A2'p)nA-dependent RNase levels during interferon treatment and cell differentiation. Eur J Biochem (1985) 1.19
Monoclonal antibodies to the thyrotropin receptor: stimulating and blocking antibodies derived from the lymphocytes of patients with Graves disease. Proc Natl Acad Sci U S A (1982) 1.18
Interaction of fragments B and C of tetanus toxin with neural and thyroid membranes and with gangliosides. J Biol Chem (1980) 1.18
Interferon-induced 2'-5' adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon. J Exp Med (1983) 1.18
Analysis of the fusion of XC cells induced by homogenates of murine leukemia virus-infected cells and by purified murine leukemia virus. J Virol (1971) 1.17
Experimental exophthalmos. Binding of thyrotropin and an exophthalmogenic factor derived from thyrotropin to retro-orbital tissue plasma membranes. J Biol Chem (1975) 1.16
Inhibition by interferon of production of double-stranded Semliki forest virus ribonucleic acid. Nature (1965) 1.16
Thyroglobulin gene expression is regulated by insulin and insulin-like growth factor I, as well as thyrotropin, in FRTL-5 thyroid cells. J Biol Chem (1987) 1.16
Lateral crural strut graft: technique and clinical applications in rhinoplasty. Plast Reconstr Surg (1997) 1.16
A mouse cell line, which is unprotected by interferon against lytic virus infection, lacks ribonuclease F activity. Eur J Biochem (1981) 1.16
The effect of interferon on de novo infection of Moloney murine leukemia virus. Cell (1977) 1.16
Calcium transport mechanisms in membrane vesicles from guinea pig brain synaptosomes. J Biol Chem (1981) 1.16
D-lactate dehydrogenase binding in Escherichia coli dld- membrane vesicles reconstituted for active transport. Proc Natl Acad Sci U S A (1974) 1.15
Calf tendon procollagen peptidase: its purification and endopeptidase mode of action. Proc Natl Acad Sci U S A (1974) 1.14
Use of thyrotropin and cholera toxin to probe the mechanism by which interferon initiates its antiviral activity. Proc Natl Acad Sci U S A (1976) 1.14
Tryptophan residues of cholera toxin and its A and B protomers. Intrinsic fluorescence and solute quenching upon interacting with the ganglioside GM1, oligo-GM1, or dansylated oligo-GM1. J Biol Chem (1981) 1.14
Induction of alpha interferon by human immunodeficiency virus type 1 in human monocyte-macrophage cultures. J Virol (1991) 1.14
Resistance of MHC class I-deficient mice to experimental systemic lupus erythematosus. Science (1993) 1.13
Hypothyroidism in transgenic mice expressing IFN-gamma in the thyroid. Proc Natl Acad Sci U S A (2000) 1.13
Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients. Biochem Biophys Res Commun (1991) 1.13
Inhibition of arbovirus protein synthesis by interferon. J Virol (1968) 1.12
Autoregulation of thyroid-specific gene transcription by thyroglobulin. Proc Natl Acad Sci U S A (1998) 1.12
Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera. J Clin Endocrinol Metab (1986) 1.12
Interferon induction by lymphocytic choriomeningitis viruses correlates with maximum virulence. J Gen Virol (1981) 1.10
Interferon-induced synthesis of 2-5A-dependent RNase in mouse JLS-V9R cells. Virology (1983) 1.10
Stimulation of interferon production in human lymphocytes by mitogens. Proc Soc Exp Biol Med (1967) 1.09
Sequence and chromosomal assignment of a novel cDNA identified by immunoscreening of a thyroid expression library: similarity to a family of mitochondrial solute carrier proteins. Mol Endocrinol (1989) 1.09